Invokana(R) for the Treatment of Type 2 diabetes China Launch Ceremony
Caption Invokana(R) for the Treatment of Type 2 diabetes China Launch Ceremony
Source Merck
Other pictures
Download
Related Press Releases Links Merck Announces Collaboration with Xian Janssen to Launch INVOKANA(R) (canagliflozin) for the Treatment of Type 2 Diabetes in China
默克宣布与西安杨森合作在中国推出2型糖尿病治疗新型药物怡可安